Income Statement atect corporation
Stocks
4241
JP3121300002
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 660.00 JPY | +5.94% |
|
+7.14% | +23.83% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.86B | 3.09B | 2.96B | 3.18B | 3.2B | |||||
Total Revenues | 2.86B | 3.09B | 2.96B | 3.18B | 3.2B | |||||
Cost of Goods Sold, Total | 1.53B | 1.51B | 1.59B | 1.8B | 1.91B | |||||
Gross Profit | 1.32B | 1.58B | 1.37B | 1.38B | 1.29B | |||||
Selling General & Admin Expenses, Total | 982M | 1.06B | 1.02B | 1.17B | 1.2B | |||||
Provision for Bad Debts | - | - | - | - | 1M | |||||
R&D Expenses | 181M | 196M | 169M | 140M | 4M | |||||
Depreciation & Amortization - (IS) | 22M | 12M | 13M | - | - | |||||
Other Operating Expenses, Total | 1.18B | 1.26B | 1.21B | 1.31B | 1.21B | |||||
Operating Income | 140M | 312M | 163M | 64M | 81M | |||||
Interest Expense, Total | -18M | -17M | -15M | -13M | -14M | |||||
Interest And Investment Income | - | - | 1M | 5M | 4M | |||||
Net Interest Expenses | -18M | -17M | -14M | -8M | -10M | |||||
Currency Exchange Gains (Loss) | 10M | 7M | 1M | 13M | -9M | |||||
Other Non Operating Income (Expenses) | 57M | 46M | 42M | 10M | 3M | |||||
EBT, Excl. Unusual Items | 189M | 348M | 192M | 79M | 65M | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 1M | 1M | - | - | - | |||||
Asset Writedown | -85M | -144M | -4M | -429M | - | |||||
Other Unusual Items | 6M | 49M | 9M | - | - | |||||
EBT, Incl. Unusual Items | 111M | 254M | 197M | -350M | 65M | |||||
Income Tax Expense | 36M | 85M | 39M | -106M | 25M | |||||
Earnings From Continuing Operations | 75M | 169M | 158M | -244M | 40M | |||||
Net Income to Company | 75M | 169M | 158M | -244M | 40M | |||||
Net Income - (IS) | 75M | 169M | 158M | -244M | 40M | |||||
Net Income to Common Incl Extra Items | 75M | 169M | 158M | -244M | 40M | |||||
Net Income to Common Excl. Extra Items | 75M | 169M | 158M | -244M | 40M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 17.04 | 38.26 | 35.74 | -55.19 | 9.05 | |||||
Basic EPS - Continuing Operations | 17.04 | 38.26 | 35.74 | -55.19 | 9.05 | |||||
Basic Weighted Average Shares Outstanding | 4.4M | 4.42M | 4.42M | 4.42M | 4.42M | |||||
Net EPS - Diluted | 17.04 | 38.26 | 35.74 | -55.19 | 9.05 | |||||
Diluted EPS - Continuing Operations | 17.04 | 38.26 | 35.74 | -55.19 | 9.05 | |||||
Diluted Weighted Average Shares Outstanding | 4.4M | 4.42M | 4.42M | 4.42M | 4.42M | |||||
Normalized Basic EPS | 26.84 | 49.23 | 27.14 | 11.17 | 9.19 | |||||
Normalized Diluted EPS | 26.84 | 49.23 | 27.14 | 11.17 | 9.19 | |||||
Dividend Per Share | 5 | 10 | 10 | 10 | 10 | |||||
Payout Ratio | 17.33 | 13.02 | 27.85 | -18.03 | 110 | |||||
Supplemental Items | ||||||||||
EBITDA | 467M | 588M | 450M | 416M | 339M | |||||
EBITA | 140M | 312M | 163M | 64M | 81M | |||||
EBIT | 140M | 312M | 163M | 64M | 81M | |||||
Effective Tax Rate - (Ratio) | 32.43 | 33.46 | 19.8 | 30.29 | 38.46 | |||||
Normalized Net Income | 118M | 218M | 120M | 49.38M | 40.62M | |||||
Non-Cash Pension Expense | 26.37M | 25.28M | 28.59M | 29.44M | 29.44M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 179M | 204M | 187M | 181M | 197M | |||||
General and Administrative Expenses | 104M | 91M | 49M | 39M | 39M | |||||
Research And Development Expense From Footnotes | 181M | 196M | 169M | 140M | 4M |
- Stock Market
- Stocks
- 4241 Stock
- Financials atect corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















